Clinical Trial Update: Open-label Study on Treatment of Primary Aldosteronism With Everolimus [Phase 2]

View source ↗

Summary

Phase 2 open-label trial evaluating everolimus for treatment of primary aldosteronism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Primary Aldosteronism | Phase 2 | Status: COMPLETED